Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Prepublished online as a Blood First Edition Paper on July 3, 2003; DOI 10.1182/blood-2002-12-3826.

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2002-12-3826v1
102/10/3815    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yvon, E. S
Right arrow Articles by Brenner, M. K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yvon, E. S
Right arrow Articles by Brenner, M. K
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted December 18, 2002
Accepted June 12, 2003

Over expression of the Notch ligand, Jagged-1 induces alloantigen-specific human regulatory T cells

Eric S Yvon, Stephane Vigouroux, Raphael F Rousseau, Ettore Biagi, Persis Amrolia, Gianpietro Dotti, Hans-Joachim Wagner, and Malcolm K Brenner*

Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA

* Corresponding author; email: mbrenner{at}bcm.tmc.edu.

Graft-versus-host disease (GvHD) represents one of the major complications of allogeneic hematopoietic stem cell transplantation. Techniques to prevent GvHD have included ex-vivo T cell depletion of the graft or prolonged in vivo immunosuppression. Both reduce the frequency and severity of GvHD but also reduce T cell mediated graft-versus-malignancy effect, and increase the risk of infection. A major goal in transplantation is to prevent alloreactivity whilst preserving activity against tumors and infectious agents. We have used activation of the Notch pathway to try to generate T cells able to specifically regulate alloantigen responses. We used allogeneic EBV-lymphoblastoid B cells (EBV-LCL) as stimulator cells. Such LCLs are excellent (allo)-antigen presenting cells and can be obtained in large numbers even from donors who have received extensive chemo/radiotherapy. We overexpressed a Notch-ligand, Jagged-1 in these cells by adenoviral vector transduction. Stimulation of CD45RA+ naive T cells by Jagged-1 reduces production of interferon-g, interleukin-2 and interleukin-5, but upregulates Transforming Growth Factor-b1 synthesis, consistent with induction of a regulatory T cell phenotype. Transfer of these cells to fresh lymphocyte cultures inhibits proliferative and cytotoxic immune responses to the priming alloantigens whilst sparing responses to third party stimulator cells. Notch activation in the presence of alloantigen presenting cells may therefore be a means of inducing specific regulatory T cells whilst preserving other T cell functionality.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
M.-T. Huang, Y.-S. Dai, Y.-B. Chou, Y.-H. Juan, C.-C. Wang, and B.-L. Chiang
Regulatory T Cells Negatively Regulate Neovasculature of Airway Remodeling via DLL4-Notch Signaling
J. Immunol., October 1, 2009; 183(7): 4745 - 4754.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. Yvon, M. Del Vecchio, B. Savoldo, V. Hoyos, A. Dutour, A. Anichini, G. Dotti, and M. K. Brenner
Immunotherapy of Metastatic Melanoma Using Genetically Engineered GD2-Specific T cells
Clin. Cancer Res., September 15, 2009; 15(18): 5852 - 5860.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
X.-L. Zhang, J. Peng, J.-Z. Sun, J.-J. Liu, C.-S. Guo, Z.-G. Wang, Y. Yu, Y. Shi, P. Qin, S.-G. Li, et al.
De novo induction of platelet-specific CD4+CD25+ regulatory T cells from CD4+CD25- cells in patients with idiopathic thrombocytopenic purpura
Blood, March 12, 2009; 113(11): 2568 - 2577.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Zhang, R. Liu, D. Shi, X. Liu, Y. Chen, X. Dou, X. Zhu, C. Lu, W. Liang, L. Liao, et al.
Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2-dependent regulatory dendritic cell population
Blood, January 1, 2009; 113(1): 46 - 57.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Rutz, M. Janke, N. Kassner, T. Hohnstein, M. Krueger, and A. Scheffold
Notch regulates IL-10 production by T helper 1 cells
PNAS, March 4, 2008; 105(9): 3497 - 3502.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Asano, T. Watanabe, A. Kitani, I. J. Fuss, and W. Strober
Notch1 Signaling and Regulatory T Cell Function
J. Immunol., March 1, 2008; 180(5): 2796 - 2804.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Chen, B. Zhao, E. Kieff, J. C. Aster, and F. Wang
EBNA-3B- and EBNA-3C-Regulated Cellular Genes in Epstein-Barr Virus-Immortalized Lymphoblastoid Cell Lines.
J. Virol., October 1, 2006; 80(20): 10139 - 10150.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Rutella, S. Danese, and G. Leone
Tolerogenic dendritic cells: cytokine modulation comes of age
Blood, September 1, 2006; 108(5): 1435 - 1440.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. Biagi, R. Rousseau, E. Yvon, M. Schwartz, G. Dotti, A. Foster, D. Havlik-Cooper, B. Grilley, A. Gee, K. Baker, et al.
Responses to Human CD40 Ligand/Human Interleukin-2 Autologous Cell Vaccine in Patients with B-Cell Chronic Lymphocytic Leukemia
Clin. Cancer Res., October 1, 2005; 11(19): 6916 - 6923.
[Abstract] [Full Text] [PDF]


Home page
Phil Trans R Soc BHome page
Z. Fehervari and S. Sakaguchi
CD4+ regulatory cells as a potential immunotherapy
Phil Trans R Soc B, September 29, 2005; 360(1461): 1647 - 1661.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. Worgall, A. Heguy, K. Luettich, T. P. O'Connor, B.-G. Harvey, L. E. N. Quadri, and R. G. Crystal
Similarity of Gene Expression Patterns in Human Alveolar Macrophages in Response to Pseudomonas aeruginosa and Burkholderia cepacia
Infect. Immun., August 1, 2005; 73(8): 5262 - 5268.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. C. Anderson, E. A. Kitchens, S. W. Chan, C. St. Hill, Y. N. Jan, W. Zhong, and E. A. Robey
The Notch Regulator Numb Links the Notch and TCR Signaling Pathways
J. Immunol., January 15, 2005; 174(2): 890 - 897.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S.-i. Tsukumo and K. Yasutomo
Notch Governing Mature T Cell Differentiation
J. Immunol., December 15, 2004; 173(12): 7109 - 7113.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Vigouroux, E. Yvon, E. Biagi, and M. K. Brenner
Antigen-induced regulatory T cells
Blood, July 1, 2004; 104(1): 26 - 33.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
T. L. Sumpter and D. S. Wilkes
Role of autoimmunity in organ allograft rejection: a focus on immunity to type V collagen in the pathogenesis of lung transplant rejection
Am J Physiol Lung Cell Mol Physiol, June 1, 2004; 286(6): L1129 - L1139.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2003 by American Society of Hematology         Online ISSN: 1528-0020